Abstract:Background A retrospective utilization study was performed to evaluate utilization patterns for enteral nutrition in a university teaching hospital. Methods Enteral nutrition was divided into three types according to the nitrogen source, ie, total protein type [Nutrison Fibre®, Fresubin Energy Fibre®, Fresubin®, Supportan® (a special immunonutrition for cancer patients or patients with increased demands for omega-3 fatty acids), Fresubin Diabetes® (a diabetes-specific formula), Ensure®]; short peptide type (Peptison®); and amino acid type (Vivonex®). A pharmacoeconomic analysis was done based on defined daily dose methodology. Results Among hospitalized patients taking enteral nutrition, 34.8% received enteral nutrition alone, 30% concomitantly received parenteral nutrition, and 35.2% received enteral nutrition after parenteral nutrition. Combined use of the different formulas was observed in almost all hospitalized patients receiving enteral nutrition. In total, 61.5% of patients received triple therapy with Nutrison Fibre, Fresubin Diabetes, and Supportan. Number of defined daily doses (total dose consumed/defined daily dose, also called DDDs) of formulas in descending order were as follows: Nutrison Fibre, Fresubin Energy Fibre, Fresubin Diabetes > Supportan > Peptison, Ensure > Vivonex, Fresubin. The ratio of the cumulative DDDs for the three types of enteral nutrition was 35:2.8:1 (total protein type to short peptide type to amino acid type). Off-label use of Fresubin Diabetes was also observed, with most of this formula being prescribed for patients with stress hyperglycemia. Only 2.1% of cancer patients received Supportan. There were 35 cases of near misses in dispensing look-alike or sound-alike enteral nutrition formulas, and one adverse drug reaction in an elderly malnourished patient who did not receive vitamin K1-enriched enteral nutrition during treatment with cefoperazone. After 4 months of the trial intervention, off-label use of Fresubin Diabetes was no longer endorsed by the Drug and Therapeutics Committee for nondiabetic patients, and the proportion of this formula prescribed for patients with stress hyperglycemia decreased by 20%, with a 10-fold increase in the amount of Supportan prescribed for cancer patients. Near misses in dispensing look-alike or sound-alike enteral nutrition were successfully abolished, and no severe coagulation disorders occurred after prophylactic administration of vitamin K1-enriched enteral nutrition in elderly malnourished patients receiving cefoperazone. Conclusion This utilization study indicates that continuous quality improvement is necessary and that a Drug and Therapeutics Committee can play an important role in promoting rational and safe use of enteral nutrition. Appropriateness of this therapy still needs to be improved, especially in addressing the issues of non-evidence-based combined use of multiple enteral nutrition formulas, the relatively high rate of concomitant use of enteral and parenteral nutrition, off-label use of diabetes-specific Fresubin Diabetes, insufficient use of Supportan in cancer patients, and unnecessary use of Supportan in intensive care patients not suffering from cancer.

Investigation of Clinical Use of the Nutrition Support Drugs in our Hospital During 2005-2006

Prescribing Practice and Evaluation of Appropriateness of Enteral Nutrition in a University Teaching Hospital

A Comprehensive Survey of the Utilization of Nutrition Preparations in Adult Inpatient in Peking University Third Hospital during 2011-2015

Analysis on the Trend of Drug Use in 22 Hospitals in Hangzhou Region During the Period from 2002 to 2004

Analysis of the Utilization of Clinical Nutrition Drugs in Our Hospital from 2007 to 2012

Early Enteral Nutrition Support Dose Selection in Critically Ill Patients: a Meta Analysis

Investigation on the Utilization of Parenteral Nutrition Preparations in 12 Hospitals of Jiangsu

Effects of different postoperative nutritional support on oxidative stress and clinical outcomes for patients after gastrointestinal surgery

Endoscopic Nasojejunal Feeding Tube Placement in Patients with Severe Hepatopancreatobiliary Diseases: a Retrospective Study of 184 Patients.

Analysis on Application of Parenteral Nutrition in Our Hospital from Jan. to Jun. in 2008

Nutritional risk screening and nutritional support of inpatients in Department of Gastroenterology, the First Hospital of Peking University, 2015

Analysis on status and trend of the consumption of enteral nutrition drugs in our hospital

A cross-sectional study on nutritional status of ICU patients in the mainland China

Survey and analysis of nutrient support drug utilization in cancer patients

An investigation on current practice of nutrition support for critically ill in Chinese ICU

Clinical analysis of enteral nutrition in 47 children

Utilization of Anti-infective Agents in Both the Outpatients and the Inpatients of Our Hospital During 2007-2009 Period

A Prospective and Descriptive Study on the Nutritional Risks, Undernutrition, and Application of Nutritional Support among Inpatients with Later but Non-End-stage Cancer in a Beijing-based Second Grade Hospital

Analysis on The Use of Oral Proton Pump Inhibitors in The Inpatients of Peking University Shenzhen Hospital During 2009-2011

A survey of nutritional support in gastrointestinal cancer patients

Investigation on the utilization of parenteral nutrition preparations and the knowledge of composing prescriptions among physicians in 12 hospitals of Jiangsu